Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806
    BD:
    North China:Mr. Xiong 15339988450
    East and South China:Ms. Gu 15378638068
    East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key model for drug development of primary sclerosing cholangitis

  Primary sclerosing cholangitis (PSCH) is a chronic cholestatic disease characterized by progressive inflammation and fibrosis of the intra- and extrahepatic bile ducts, which in turn leads to multifocal bile duct strictures. Most patients eventually develop cirrhosis, portal hypertension and hepatic decompensation.
  We have established a stable model of trinitrobenzene sulfonic acid (TNBS)-induced primary sclerosing cholangitis , which is suitable for preclinical studies of drugs for primary sclerosing cholangitis and evaluation of new drugs.
  Please contact us for your project needs and to experience more of our professional services.

Our services

Model classification

Model Name

Animal species

Primary sclerosing cholangitis

Model of primary sclerosing cholangitis induced by 

trinitrobenzene sulfonic acid (TNBS)

Rats


Case sharing

Next:Acute pancreatitis